Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.8124
-0.0976 (-10.73%)
At close: Mar 13, 2026, 4:00 PM EDT
0.7962
-0.0162 (-1.99%)
After-hours: Mar 13, 2026, 7:36 PM EDT
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $71.71 million as of March 13, 2026. Its market cap has decreased by -15.06% in one year.
Market Cap
71.71M
Enterprise Value
68.22M
1-Year Change
-15.06%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has decreased from $90.21M to $71.71M, a decrease of -20.51%. That is a compound annual growth rate of -6.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 80.33M | -5.27% |
| Dec 31, 2025 | 84.80M | 3.05% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BGM Group | 185.80M |
| Alpha Teknova | 145.22M |
| Cardiol Therapeutics | 119.92M |
| Assertio Holdings | 73.79M |
| Incannex Healthcare | 71.31M |
| Cumberland Pharmaceuticals | 46.07M |
| InterCure | 43.96M |
| Talphera | 41.79M |